Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Sylwia Zielinska, RN

      home / authors / sylwia-zielinska-rn

      Sylwia Zielinska, RN, is a registered nurse at Vanderbilt University Medical Center.

      Articles


      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      RX Road Map: Daratumumab and Hyaluronidase-fihj

      Sylwia Zielinska, RN
      May 7th 2025

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.

      Latest Updated Articles

      Anatomical image of a breast with a tumor
      Published: April 17th 2025 | Updated: May 5th 2025
      Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer
      Photo of a woman with her hand on her forehead in stress
      Published: April 14th 2025 | Updated: April 16th 2025
      Opinion: Crowdfunding Falls Short in Gynecologic Cancer
      Graphic reading "FDA APPROVED" resembling a stamp of approval
      Published: March 28th 2025 | Updated: March 31st 2025
      FDA Approves Perioperative Durvalumab Plus Chemotherapy for MIBC
      Photo of a hospital bathroom with a Splashblocker toilet seat cover hung on the wall next to it
      Published: March 17th 2025 | Updated: March 24th 2025
      Splashblocker May Reduce Toilet Plume Aerosols in Oncology Setting
      Screen capture of Seth Eisenberg, ASN, RN, OCN, BMTCN, on a video call with an Oncology Nursing News branded border around the frame
      Published: March 23rd 2025 | Updated: March 24th 2025
      Toilet Cover May Significantly Reduce Aerosol Exposure in Hospital Bathrooms
      Model of multiple myeloma cells
      Published: February 27th 2025 | Updated: March 3rd 2025
      Cilta-Cel Associated With Higher HRQOL for Lenalidomide-Refractory MM

      Latest Conference Coverage

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Acupuncture Use in BC Predicted by Social Determinants of Health

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.